Anthropic Mythos, previewed in April, is a system that detects software vulnerabilities, but cybersecurity experts have warned that it coul...

Bajaj Auto confirmed a ransomware attack on Tuesday, affecting its systems and those of its unit, Bajaj Auto Technology. The automotive gia...

Healthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...

The intelligence alliance commonly known ⁠as the "Five ⁠Eyes" said in a three-page statement that, "Frontier AI models are anticipated to e...

Tata Electronics has confirmed a cybersecurity incident, with ransomware group World Leaks claiming to have posted sensitive design and spe...

The Bombay High Court has cancelled Thane-based Menschlich Healthcare's trademark 'Duphachrit' in favour of Abbott Product Operations AG. T...

Axis Bank assures its digital systems are secure. The bank states cyber fraud largely occurs when customers are tricked by external communi...

Jaguar Land Rover is adjusting its strategy. The company will offer a mix of petrol, hybrid, and electric vehicles. This change comes after...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...

European shares surged on Friday, driven by renewed hopes for a Middle East diplomatic breakthrough that lowered oil prices. The pan-Europe...

The benchmark snapped a four-day losing streak on Thursday, as ⁠investors digested the European Central Bank's rate hike and largely looked...

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...

Danish drugmaker Novo Nordisk has confirmed a security incident. Unauthorised access to internal IT systems occurred. Certain non-public da...

India's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...

Lilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...

Eli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...

Novo Holdings is investing 500 million euros in the new Scaleup Europe Fund. This pan-European fund aims to support technology companies th...